<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20181126041760N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2019-07-23</date_registration>
      <primary_sponsor>Shahid Beheshti University of Medical Sciences</primary_sponsor>
      <public_title>comparison  the effect  of Erector Spinae Block VS Pectoral 1  Block on post operative pain , nausea and vomiting in breast mass surgeries ; a double blind randomized study</public_title>
      <acronym></acronym>
      <scientific_title>comparison  the effect  of Erector Spinae Block VS Pectoral 1  Block on post operative pain , nausea and vomiting in breast mass surgeries ; a double blind randomized study</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2019-05-08</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>64</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/39783</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Health service research, Randomization description: Related code was given to all patients   by Computer based on Random number table and the patients were divided in two groups (simple randomization) . In one group the second anesthesiologist who wasn't aware from research type, blocked the patients based on closed envelope which include the type of block. The main researcher was not aware about the block was used for each patient, Blinding description: Patients and the anesthesiology resident were not aware about type of blocks. although the patient was aware and consent about Nerve block benefits, anesthesiologist who did the block was not participated in complition of questioner.</study_design>
      <phase>3</phase>
      <hc_freetext>Analgesia in chest wall operations.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: pecs1 block/ after consent for regional block , qualified person put in table of random numbers.before general anesthesia in aseptic field on sonography guide we did pecs1 block(20cc rupivacaine .25%).patients received  drugs for general anesthesia.BIS was monitored(40-60).after surgery in full awake patients we measured pain(VAS score),nausa,need for narcotic,vomiting. Intervention 2: Intervention group:erector soinae block/ after consent for regional block , qualified person put in table of random numbers.before general anesthesia in aseptic field on sonography guide we did erector spinae block (20cc rupivacaine .25%).patients received  drugs for general anesthesia.BIS was monitored(40-60).after surgery in full awake patients we measured pain(VAS score),nausa,need for narcotic,vomiting.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
all data will be published without identifying personal identities.

When:
almost 6 months after result publication

To whom:
َll persons

Conditions:
After contacting with corresponding author, dr.Houman Teymourian

Where to obtain:
Houman Teymourian

How to obtain:
1 week after contacting with corresponding author Houman Teymourian

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Houman Teymourian</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Anesthesia department, Shohada Tajrish hospital, Shahrdari street, Tajrish squer, Tehran, Iran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1989934148</zip>
        <telephone>+98 21 2274 1174</telephone>
        <email>houman72625@yahoo.com</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Houman Teymourian</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>tajrish square</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1989934148</zip>
        <telephone>+98 21 2274 1174</telephone>
        <email>dr.teymourian@sbmu.ac.ir</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>women age 18-50
ASA class 1-2
insensitivity to LA
No psychotic disorder
No addiction
no hemostasis disorder
no local skin infection
no use analgesic and NSAID drugs</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>50 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>operation time more than 4 hours
excessive blood loss
changing procidure type</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>N60</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>benign mammary dysplasia   skin of breast</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Other</i_code>
      <i_code>Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: pecs1 block/ after consent for regional block , qualified person put in table of random numbers.before general anesthesia in aseptic field on sonography guide we did pecs1 block(20cc rupivacaine .25%).patients received  drugs for general anesthesia.BIS was monitored(40-60).after surgery in full awake patients we measured pain(VAS score),nausa,need for narcotic,vomiting.</i_keyword>
      <i_keyword>Intervention group:erector soinae block/ after consent for regional block , qualified person put in table of random numbers.before general anesthesia in aseptic field on sonography guide we did erector spinae block (20cc rupivacaine .25%).patients received  drugs for general anesthesia.BIS was monitored(40-60).after surgery in full awake patients we measured pain(VAS score),nausa,need for narcotic,vomiting.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>PAIN. Timepoint: recovery/60minutes after recovery/2hours after recovery/4hours after recovery/6hours after recovery. Method of measurement: visual analogue scale.</prim_outcome>
      <prim_outcome>Nausea. Timepoint: recovery/60minutes after recovery/2hours after recovery/4hours after recovery/6hours after recovery. Method of measurement: questionnaire.</prim_outcome>
      <prim_outcome>Vomiting. Timepoint: recovery/60minutes after recovery/2hours after recovery/4hours after recovery/6hours after recovery. Method of measurement: questionnaire.</prim_outcome>
      <prim_outcome>Blood Pressure. Timepoint: after injection/15minutes after/30minutes after/45minutes after/60minutes after/75minutes after/90minutes after/2hours after/3hours after/4hours after/6hours after. Method of measurement: BP monitoring (mmhg).</prim_outcome>
      <prim_outcome>Herat rate. Timepoint: after injection/15minutes after/30minutes after/45minutes after/60minutes after/75minutes after/90minutes after/2hours after/3hours after/4hours after/6hours after. Method of measurement: HR monitoring.</prim_outcome>
      <prim_outcome>Need for narcotic. Timepoint: Recovery/60 minutes after recovery/2 hours after recovery/4 hours after recovery/6 hours after recovery. Method of measurement: patient file (macrogram).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shahid Beheshti University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2019-05-08</approval_date>
        <contact_name>ethics research of shahid beheshti university of medical sciense</contact_name>
        <contact_address>ERABI STREET tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
